1 The aim of the present study was to examine the contractile responses evoked by the recently -characterized vasoactive peptide endothelin-1 (ET-1) and by two of its structural analogues, [Ala3',]ET-1 and [Ala"'5]ET-1 in endothelium-denuded rat isolated aorta, and also to assess the extent of dependence of these responses on extracellular calcium entry. 6 Upon readdition of calcium (10pM to 10mM) to tissues in calcium-free medium, preincubated with submaximal concentrations of one or the other of the peptides, concentration-dependent contractions were elicited with EC50 values of 1.21 + 1.1 mm (ET-1-exposed rings), 74.6 + 9.1 Mm ([Ala31']ET-1-exposed rings) and 102 + 27pM ([Ala' 15]ET-1-exposed rings). Calcium-induced responses were significantly inhibited by diltiazem (1 gM) in both ET-1-and [Ala3"1 ']ET-1-exposed tissues and by nifedipine (0.1 and 1 gM) in ET-1-exposed tissues. However, nifedipine did not significantly affect calcium induced responses in [Ala"'15]ET-1-exposed rings.
Introduction
A potent vasoactive peptide was identified in the named endothelin . Recently medium of porcine endothelial cells in culture and it has been reported that there is a family of related peptides and the peptide that was originally Author for correspondence.
described has been designated endothelin-1 (ET-1; Inoue et al., 1989) . However, ET-1 has since been demonstrated to exert multiple actions. It is a potent secretagogue, releasing atrial natriuretic factor from rat myocytes (Fukuda et al., 1988) , inhibits renin release from rat glomeruli (Rakugi et al., 1988) , has positive inotropic effects on guinea-pig atria (Ishikawa et al., 1988) , contracts guinea-pig ileal smooth muscle, interferes with sympatheticallyinduced twitch responses in the rat vas deferens and possesses bronchoconstrictor qualities (Uchida et al., 1988) . Early reports suggested that its vasoconstrictor effects were dependent to a large extent on extracellular calcium and were inhibited by the dihydropyridine calcium entry blockers nifedipine and nicardipine . These observations correlate with the reported failure of the peptide to induce accumulation of phosphoinositides in rat vascular smooth muscle cells in culture . More recent data however, suggest that calcium entry through dihydropyridine-sensitive calcium channels might play only a minor role in the vasoconstrictor responses to the peptide (Auguet et al., 1988; Hagiwara et al., 1988; Miasiro et al., 1988) .
Therefore, it was of interest to study the dependence on extracellular calcium of responses to ET-1 in rat aorta in vitro. The role of intracellular and extracellular calcium in agonist-induced contractile responses and the effects of calcium entry blockers thereon have been extensively studied in this artery (Godfraind et al., 1986 ). Few structure-activity studies of the bicyclic peptide ET-1 have been undertaken, but disulphide bonds in cyclic peptides such as somatostatin, oxytocin and atrial natriuretic factor for example are required for maintaining their biologically active conformations (Veber & Saperstein, 1979; Misono et al., 1984 , Hruby, 1985 . The relative importance of the disulphide bonds for the activity of ET-1 is therefore an interesting question, and this has been assessed by comparing its activity with that of two analogues, [Ala31 1]-and [Ala"'5] ET-1. The results show that contractions elicited by ET-1 and some of its vasoactive analogues can be partially antagonized by the calcium entry blockers diltiazem and nifedipine. Elimination of one or other of the disulphide bonds by replacement of the appropriate cysteine residues with alanine, reduced potency and changed some of the functional characteristics of the peptide in this tissue.
A preliminary account of this work has been published (Topouzis et al., 1989 (Furchgott & Zawadzki, 1980 It has been suggested that ET-1 may activate calcium channels elicited by the same concentrations of the peptides in normal medium. These residual contractions to ET-1 were not affected by either diltiazem (1 MM) or nifedipine (1 MM), those to [Ala3" ']ET-1 were not affected by diltiazem (1 Mm) and those to [Ala"'5]ET-1 were not affected by nifedipine (0.1 uM) (Figure 5 (Figure 5d ) and analysis of variance indicated no significant difference between these 2 concentration-effect curves (P = 0.498). Readdition of calcium to tissues exposed to 0.3 gM noradrenaline in the absence of Ca2+ also elicited concentrationdependent responses (Figure 6 ). In the presence of diltiazem, 1 yM, these concentration-effect curves were significantly shifted to the right, the EC50 values were increased by about 3 fold (P < 0.012) and the maximal responses depressed (P = 0.046).
In the presence of 40 mm K+ and the absence of calcium, residual responses to 3 nM ET-1 were unchanged compared to those in a Ca2 +-free medium with a normal concentration of K+. Readmission of calcium (tOyM to 10mM) to tissues in Ca2+-free medium containing 40mm K+, induced concentration-dependent contractions with an EC50 value of 0.7 + 0.2 mm (n = 4). In the presence of both 3nM ET-1 and 40mM K+, EC50 values for Ca2+ (0.4+0.1mM, n=4) were not significantly altered and neither were maximal responses (t-test; Figure  7 ). Analysis of variance did not demonstrate any significant difference (P = 0.301).
Discussion
Endothelin (ET-1) was recently described as a vasoconstrictor peptide released from endothelial cells in culture . This peptide and markedly affect maximal evoked responses. Alanine was chosen to replace the cysteine residues because this substitution retains a chiral amino acid, it is also a neutral residue and does not introduce any new charge at the substituted position and is pseudo isosteric with cysteine. Evidently, the presence of both disulphide bonds is not essential for activity of ET-1. However, inhibition of the formation of one or other of these bonds by the inclusion of blocking groups on the sulphur of the appropriate cysteine residues results in reduction or loss of activity (Hirata et al., 1989) . This probably indicates that steric hindrance from the large blocking groups distorts the tertiary structure of the peptide while simple removal of one or other of the bridges has a relatively small effect. log (Calcium, M) Figure 6 Contractions induced by calcium in rat isolated aortic rings exposed to 0.3 yM noradrenaline in the absence (0) and presence (0) (Godfraind et al., 1986) . Diltiazem antagonized contractions elicited by ET-1 in normal calcium-containing medium. However, the concentration-effect curves in the presence of diltiazem were parallel to those obtained in its absence and maximal responses were unchanged (Figure 2a) Godfraind & Dieu, 1981; Godfraind & Miller, 1983 (Jones et al., 1989) , the results indicate that the antagonism by diltiazem of ET-1-induced responses is unlikely to be due to an effect at ET-1 receptors. Also, diltiazem and ET-1 do not interact with each others specific binding sites Van Renterghem et al., 1988 (Godfraind et al., 1986 ). This inhibition is unlikely to be due to an effect on ET-1 receptors since dihydropyridines do not interact with ET-1 binding sites Van Renterghem et al., 1988 (Godfraind & Miller, 1983) . Contractions induced by readdition of calcium to tissues in calcium-free medium in the presence of ET-1 were also antagonized by nifedipine in a 20 C.) z08 40 -5 -4.5 -4 -3.5 -3 -2.5 -2 log (Calcium, M) Figure 7 Contractions induced by calcium in rat isolated aorta in a solution containing 40mM K+ in the absence (0) and presence (@) of 3 nM endothelin. Vertical bars represent s.e.mean of 4 observations. manner that would be expected if dihydropyridine sensitive calcium channels were being activated (Godfraind, 1983) . Overall, these experiments using nifedipine are in agreement with reports of antagonism of ET-1-mediated responses by dihydropyridines and therefore with the idea that ET-1 activates dihydropyridine-sensitive calcium channels . However, it has been reported that ET-1-induced contractions in rat aorta were not antagonized by diltiazem, D600 or nifedipine (Auguet et al., 1988) . Also, ET-1 did not potentiate calcium-induced contractions in depolarized tissues (Figure 7) . The calcium channel activator, Bay K 8644, enhances contractions (Hwang & van Breemen, 1985) and 45Ca influx (Chiu et al., 1986) Figure 5 ). The reason for this difference is unknown at present but it might indicate that ET-1 is a less effective activator of membrane channels that permit the passage of calcium than are the other analogues. Alternatively the analogues might reduce calcium extrusion from the cells to a greater extent than ET-1. To summarize, the results obtained in this study using diltiazem and nifedipine suggest that there is a limited role for extracellular calcium entry via L-type calcium channels in the responses to ET-1 and to its analogues. This may be because ET-1 and its analogues only activate these channels secondarily to the activation of other channels that permit the entry of extracellular calcium (Van Renterghem et al., 1988) .
